Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07208864

Efficacy of an AI System in Training Endoscopists to Assess Gastric Intestinal Metaplasia Via the EGGIM Score

Efficacy of an AI System in Training Endoscopists to Assess Gastric Intestinal Metaplasia Via the EGGIM Score: A Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This prospective randomized controlled trial with a crossover design incorporated image-enhanced endoscopy (IEE) videos demonstrating complete standardized examinations of five standard gastric areas (antrum greater curvature, antrum lesser curvature, incisura, corpus lesser curvature, and corpus greater curvature). Endoscopists were stratified by experience level and randomly assigned to either the AI-assisted scoring first group, which performed EGGIM scoring with AI assistance in the initial phase followed by conventional scoring after a washout period, or the conventional scoring first group, which completed the assessments in reverse order. The study primarily evaluated the training efficacy of the EGGIM-AI system for improving endoscopists' EGGIM scoring performance by comparing diagnostic accuracy metrics including the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity between groups at different study phases, with histopathological results serving as the gold standard.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAI-assisted EGGIM scoringEndoscopists will evaluate the videos with the assistance of the AI system via EGGIM score.
DIAGNOSTIC_TESTConventional EGGIM scoringEndoscopists will evaluate the videos without the assistance of the AI system via EGGIM score.

Timeline

Start date
2025-11-30
Primary completion
2026-05-31
Completion
2026-12-31
First posted
2025-10-06
Last updated
2025-12-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07208864. Inclusion in this directory is not an endorsement.